UAE approves Rinvoq for vitiligo in patients 12+ as first oral systemic option
EDE approved once-daily Rinvoq for eligible non-segmental vitiligo patients. Clinics need prescribing, price and insurance checks.
20 Aug 2026 · 3 min read
Topic
upadacitinib
1 articles